HB 2874 creates rules for air ambulance membership plans, which are non-insurance programs that let people pay for air ambulance services in advance. It directly affects Missouri residents enrolled in MO HealthNet (Missouri's Medicaid program), as these individuals cannot purchase or renew such memberships. Key provisions require membership organizations to: (1) stop selling to MO HealthNet enrollees, (2) offer a partial refund or transfer if someone joins Medicaid during their membership, and (3) clearly state in all marketing and applications that the plan is not insurance and Medicaid beneficiaries are ineligible. The bill also mandates specific disclosures about Medicaid ineligibility and prohibits marketing to Medicaid members. Violations can be reported to the state Attorney General for enforcement.
HB 2702 sets new standards for establishing a doctor-patient relationship before providing telemedicine services in Missouri. It requires that this relationship be created through an in-person visit, consultation with another physician, or a telemedicine encounter that meets specific clinical and technological standards - prohibiting prescriptions based solely on internet questionnaires or telephone calls without a prior established relationship. The bill mandates that telemedicine providers review patient medical history, perform sufficient examinations via technology, and send a written report to the patient’s primary care provider within 14 days, including diagnosis and treatment details. These provisions apply to all healthcare providers using telemedicine for prescribing medications or treatments under Missouri law.
HB 3136 restricts Missouri's ability to operate a state-run health insurance marketplace (often called a "health exchange" under federal law). It requires specific legislative approval - via bill, initiative, or referendum - before any state agency can establish, administer, or fund such a marketplace, banning executive orders or informal actions. The bill also prohibits state entities from using federal funds for these exchanges without explicit authorization and blocks agreements with federal authorities to create or operate a federal-facilitated exchange. This directly affects Missouri state departments, agencies, and political subdivisions that might otherwise engage with the federal health care law's marketplace system.
HB 2888 limits claims for future medical monitoring in civil lawsuits. It states that merely having a toxic substance in the body (without a diagnosable disease) doesn't qualify for compensation. To recover future monitoring costs, plaintiffs must prove: (1) the monitoring is directly tied to a current, diagnosed illness; (2) it goes beyond standard care; and (3) the illness was caused by the defendant's negligence. This bill directly affects individuals filing lawsuits related to exposure to harmful substances, such as environmental or workplace toxins.
HB 2960 would allow consumers in this state to purchase ivermectin over-the-counter without a prescription or consultation with a pharmacist or healthcare provider. This bill directly affects individuals seeking ivermectin and pharmacies that sell it, removing current requirements for medical oversight. The key provision amends state law to permit unrestricted retail sales of ivermectin as a non-prescription product. The bill was introduced in the House on January 13, 2026, and is pending further legislative action.
SJR 107 would repeal Article I, Section 36 of the state constitution, which established the "Right to Reproductive Freedom Initiative." This constitutional provision currently protects certain reproductive healthcare rights. The bill directly affects the state's constitutional framework by removing this specific provision. As a procedural measure, it does not create new policy but changes the existing constitutional text. (2 sentences)
HB 2594 would allow consumers to purchase hydroxychloroquine and ivermectin tablets over-the-counter without a prescription or consultation with a pharmacist or healthcare provider. The bill directly affects residents seeking these specific medications by removing current prescription requirements. Key provisions include amending state law to permit direct public access to both drugs and declaring the law an emergency act to take immediate effect upon passage. The bill is currently in early legislative stages, having been prefilled and read for the first time in 2026.
HB 1881 amends Missouri's controlled substances law by adding specific fentanyl analogs and synthetic opioids to Schedule I (not Schedule III, as the title states). The bill lists numerous fentanyl derivatives (e.g., acetyl fentanyl, xylazine is not listed) and opioid compounds under Schedule I, which requires they have high abuse potential and no accepted medical use. This change directly affects law enforcement, healthcare providers, and individuals handling these substances by classifying them as illegal under Missouri law. The bill does not mention xylazine in its text; the title appears to contain an error, as the actual provisions focus on fentanyl-related compounds. This is a substantive policy change to drug scheduling, not a procedural measure.
HB 1608 would prohibit health care providers from performing gender transition surgeries or prescribing cross-sex hormones or puberty-blocking drugs to individuals under 18 for the purpose of gender transition, with exceptions for medically verified disorders of sex development. Violations could result in license revocation for providers and allow lawsuits seeking up to three times the damages (with a $500,000 minimum) for harm like infertility. The bill also creates a legal presumption of harm for infertility linked to such treatments, allowing lawsuits to be filed within 15 years of the minor turning 21. This legislation is currently pending in committee after recent hearings and has not yet been enacted.
HB 2556 reserves specific medical titles and specialty designations (like "MD," "Cardiologist," or "Pediatrician") exclusively for licensed physicians. It prohibits non-physicians - including nurses, therapists, or other healthcare providers - from using these titles, with limited exceptions for chiropractors, physician assistants, and speech-language pathologists. The bill also allows patients to sue non-physicians who misuse reserved titles for damages, injunctions, or penalties, and permits licensing boards to discipline violators. This policy change directly affects healthcare providers seeking to use medical titles and patients receiving care from those providers.
